A61N5/1027

METHOD FOR IMPLEMENTING A STAPLE SYSTEM

Staple systems and methods for implementing the staple systems are disclosed.

ABSORBABLE SURGICAL STAPLES COMPRISING SUFFICIENT STRUCTURAL PROPERTIES DURING A TISSUE HEALING WINDOW

Bioabsorbable staples are disclosed that have sufficient mechanical properties throughout a healing window of patient tissue.

ABSORBABLE STAPLE COMPRISING STRAIN LIMITING FEATURES

Staple cartridges comprising absorbable staples having sufficient mechanical properties to be deployed into patient tissue, clench the patient tissue, and then dissolve within a desired time frame.

ABSORBABLE SURGICAL STAPLE COMPRISING AT LEAST TWO COATINGS

A staple cartridge comprising absorbable staples having co-operate and/or antagonistic coatings is disclosed.

ADAPTIVE CONTROL OF SURGICAL STAPLING INSTRUMENT BASED ON STAPLE CARTRIDGE TYPE

A method and apparatus of adaptively controlling a surgical stapling instrument are disclose. The method includes identifying a staple cartridge type, configuring the surgical stapling instrument based on the identified staple cartridge, and adaptively controlling, by a control circuit, operation/functionality of the surgical stapling instrument based on the configuration of the surgical stapling instrument loaded with the identified staple cartridge type. The apparatus includes a control circuit including a microcontroller and a memory coupled to the microcontroller. The memory stores machine executable instructions that when executed by the microcontroller cause the microcontroller to execute the above method.

PACKAGING ASSEMBLIES FOR SURGICAL STAPLE CARTRIDGES CONTAINING BIOABSORBABLE STAPLES

Packaging assemblies for storing and shipping surgical staple cartridges containing bio-absorbable staples.

DUAL MODALITY ENDOCAVITY BIOPSY IMAGING SYSTEM AND METHOD

A dual modality endocavity imaging and treatment system for detection of cancer and targeted biopsy and treatment procedures, comprising: a housing; a nuclear detector system housed within the housing and configured for detecting nuclear radiation imaging data; an ultrasound detector system housed within the housing for detecting ultrasound imaging data; a needle associated with the housing and adjustably positionable relative thereto; and a data processing module configured to receive the nuclear radiation imaging data and the ultrasound imaging data and to generate and output an image showing the relative position of the needle and an endocavity object of interest. The needle may include a distinct radiation signature to facilitate imaging thereof.

SYSTEM FOR SUPPORTING A BRACHYTHERAPY TREATMENT, METHOD FOR PROVIDING A SUPERVISION INFORMATION AND COMPUTER PROGRAM PRODUCT
20220288417 · 2022-09-15 ·

A system for supporting a brachytherapy treatment includes a medical imaging system and a processing unit. The medical imaging system includes a SPECT unit and/or a CT unit. The processing unit is configured to receive a planning dataset, and determine a brachytherapy treatment plan based on the planning dataset. The treatment plan includes a planned dose distribution for a radiation source. The medical imaging system is configured to acquire a supervision dataset that includes an intra-procedural representation of the radiation source that, in an operating state of the system, has been positioned at a treatment site within a treatment region via a medical guide instrument. The processing unit is configured to register the supervision dataset and the planning dataset, determine an actual dose distribution based on the supervision dataset, and provide supervision information based on a comparison between the planned and actual dose distribution.

Instrument for therapeutically cytotoxically ablating parathyroidal tissue within a parathyroid gland
11406438 · 2022-08-09 ·

An instrument for therapeutically cytotoxically ablating parathyroidal tissue is disclosed. A substance is capable of transforming the parathyroid gland from overproduction of parathyroid hormone when the substance's quantity exceeds a set amount, and is capable of transforming the parathyroid gland from overproduction only when activated by application of sufficient units of an electromagnetic energy having a frequency ranging from 400 THz to 30 PHz when the substance's quantity is below the set amount. A delivery device is operable to introduce the substance into the parathyroidal tissue and to quantitatively limit the quantity to below the set amount. An energy device is operable to apply units of the electromagnetic energy after the substance has been introduced. A sensor is operable to monitor the activation of the substance as the electromagnetic energy is applied. The energy device is further operable to modulate applying the electromagnetic energy when the substance has been activated.